Sutro Biopharma, Inc. (STRO) - Comprehensive Stock Analysis & Investment Research
Deep dive into Sutro Biopharma, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.
Sutro Biopharma, Inc. Investment Summary
When evaluating whether Sutro Biopharma, Inc. (STRO) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.
Company Profile
Sutro Biopharma, Inc. (STRO) operates within the Life Sciences sector, specifically in the Biological Products, (No Diagnostic Substances) industry. . With a market capitalization of $391 million, the company is a small-cap stock that may offer higher growth potential but also carries higher volatility.
Financial Performance Analysis
Our comprehensive financial analysis covers Sutro Biopharma, Inc.'s revenue, profitability metrics, balance sheet strength, and cash flow generation...
AI Price Predictions
Get AI-powered 7-day, 30-day and 90-day price forecasts for Sutro Biopharma, Inc. along with confidence scores and detailed analysis...
Investment Considerations
Expert analysis of whether Sutro Biopharma, Inc. is suitable for your investment objectives, risk tolerance, and time horizon...
Corporate Identity
Sutro Biopharma, Inc. (Stock Symbol: STRO) is a prominent company operating within the Life Sciences sector, with a specific focus on the Biological Products, (No Diagnostic Substances) industry. The company's shares are publicly traded on the Nasdaq exchange.
Leadership & Workforce
Detailed information about Sutro Biopharma, Inc.'s leadership team, workforce size, and organizational structure...
Market Classification
Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Sutro Biopharma, Inc....
Sector & Industry Analysis
In-depth sector dynamics and industry context for Sutro Biopharma, Inc....
Revenue & Growth Analysis
Sutro Biopharma, Inc. generates annual revenues of $99 million , representing an emerging company in its growth phase.
Profitability Metrics
Net profit margin, gross margin, and operating margin analysis for Sutro Biopharma, Inc....
Market Valuation
P/E ratio, price-to-book, and valuation multiples for Sutro Biopharma, Inc....
Return Metrics
Return on equity (ROE), return on assets (ROA), and capital efficiency for Sutro Biopharma, Inc....
Strategic Market Position
Sutro Biopharma, Inc. strategically competes in the highly dynamic Biological Products, (No Diagnostic Substances) marketplace. As a small-cap company, it represents an emerging market participant with potentially significant growth opportunities. Small-caps often offer greater growth potential as they capture market share and scale their operations, though this comes with higher risk and volatility. Success at this stage can lead to substantial returns for early investors who identify winning business models.
Industry Competitive Landscape
Sutro Biopharma, Inc. competes within the Life Sciences sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.
Operational Efficiency
Asset Utilization Efficiency
Asset turnover ratio of 0.41x indicates moderate asset turnover common in capital-intensive industries such as utilities, real estate, or heavy manufacturing. Lower turnover in these sectors is expected due to the significant infrastructure required for operations.
Financial Strength & Leverage
Current ratio of 3.12 demonstrates strong short-term liquidity with current assets significantly exceeding current liabilities. This provides a substantial buffer for meeting near-term obligations and handling unexpected financial needs.